Search Results - Nayiyuan Wu
- Showing 1 - 1 results of 1
-
1
Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more by Zhi-Bin Wang, Zhi-Bin Wang, Dan Liu, Guang Lei, Zhao-Qian Liu, Zhao-Qian Liu, Nayiyuan Wu, Nayiyuan Wu, Jing Wang, Jing Wang
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book